140 related articles for article (PubMed ID: 1371723)
1. Ratio of serum tartrate-inhibitable acid phosphatase to total serum protein in benign prostatic hypertrophy and prostatic carcinoma.
Petrovich G; Ursich-Jankovich J; Prijovich Z
Clin Chem; 1992 Feb; 38(2):276-7. PubMed ID: 1371723
[TBL] [Abstract][Full Text] [Related]
2. [Total and tartrate-inhibited acid phosphatases in serum. Significance of rectal examination in normal individuals and patients with benign prostatic hypertrophy].
Nielsen ML; Christensen P; Antoni E
Ugeskr Laeger; 1971 Nov; 133(46):2279-84. PubMed ID: 4109415
[No Abstract] [Full Text] [Related]
3. ROC plots display test accuracy, but are still limited by the study design.
Zweig MH
Clin Chem; 1993 Jun; 39(6):1345-6. PubMed ID: 7684958
[No Abstract] [Full Text] [Related]
4. [Prostatic acid phosphatase measured by immunoenzyme assay].
Fuse H; Zama S; Shimazaki J
Hinyokika Kiyo; 1985 Nov; 31(11):1957-64. PubMed ID: 2418660
[TBL] [Abstract][Full Text] [Related]
5. Acid phosphatase in prostatic tissue homogenates from patients with benign prostatic hyperplasia and prostatic carcinoma.
Copland GT; Whitehurst GB; Pretlow TP; Boohaker EA; Bartolucci AA; Pretlow TG
Cancer; 1983 Jul; 52(1):155-60. PubMed ID: 6189580
[TBL] [Abstract][Full Text] [Related]
6. Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
Salo JO; Rannikko S; Haapiainen R
Br J Urol; 1990 Aug; 66(2):188-92. PubMed ID: 1697205
[TBL] [Abstract][Full Text] [Related]
7. TARTRATE-INHIBITED ACID PHOSPHATASE IN BENIGN PROSTATIC HYPERTROPHY AND IN PROSTATIC CANCER.
LANDBERG T
Acta Chir Scand; 1964 Oct; 128():435-41. PubMed ID: 14211297
[No Abstract] [Full Text] [Related]
8. Rapid radioimmunoassay for prostate-specific acid phosphatase in human serum.
Vihko P; Kostama A; Jänne O; Sajanti E; Vihko R
Clin Chem; 1980 Oct; 26(11):1544-7. PubMed ID: 6158382
[TBL] [Abstract][Full Text] [Related]
9. TARTRATE-INHIBITED ACID PHOSPHATASE IN BENIGN PROSTATIC HYPERTROPHY AND IN PROSTATIC CANCER.
JACOBSSON K; LANDBERG T
Acta Chir Scand; 1964 Apr; 127():415-26. PubMed ID: 14149644
[No Abstract] [Full Text] [Related]
10. [Critical study of acid phosphatases in benign prostatic hypertrophy].
Rodrigues Netto Júnior N; de Andrade AC; Lemos GC; de Araujo JT
AMB Rev Assoc Med Bras; 1982; 28(3-4):93-5. PubMed ID: 6189151
[No Abstract] [Full Text] [Related]
11. Comparison of prostatic acid phosphatase assays.
Wise WS; Kandaswamy K
Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
[TBL] [Abstract][Full Text] [Related]
12. Development and clinical evaluation of two immunoassays for prostatic acid phosphatase in serum.
de Vries GP; Sanders GT
Am J Clin Pathol; 1982 Aug; 78(2):189-95. PubMed ID: 6179425
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of serum prostatic acid phosphatase assay based on the immunoenzymatic method (TZR-516)].
Ikemoto I; Machida T; Oishi Y; Onishi T; Shirai T; Imanaka K
Hinyokika Kiyo; 1989 Sep; 35(9):1639-42. PubMed ID: 2479240
[TBL] [Abstract][Full Text] [Related]
14. Enzyme markers in human prostatic carcinoma.
Chu TM; Wang MC; Kuciel R; Valenzuela L; Murphy GP
Cancer Treat Rep; 1977; 61(2):193-200. PubMed ID: 68822
[TBL] [Abstract][Full Text] [Related]
15. Elevation of serum prostatic acid phosphatase levels after prostatic massage.
Wadström J; Huber P; Rutishauser G
Urology; 1984 Dec; 24(6):550-1. PubMed ID: 6209846
[TBL] [Abstract][Full Text] [Related]
16. The use of L-tartrate in determining prostatic serum acid phosphatase: a report of 514 cases.
MATHES G; RICHMOND SG; SPRUNT DH
Trans Southeast Sect Am Urol Assoc; 1955; (19th Meeting):58-65. PubMed ID: 13274458
[No Abstract] [Full Text] [Related]
17. [ATTEMPTED MEASUREMENT OF LABILE TARTRATE ACID PHOSPHATASE].
MICHON L; BESSON R
Acta Urol Belg; 1964 Jan; 32():86-7. PubMed ID: 14111386
[No Abstract] [Full Text] [Related]
18. The effect of rectal examination on serum acid phosphatase levels in benign and malignant prostatic disease.
Osegbe DN; Magoha G
Postgrad Med J; 1982 Dec; 58(686):763-6. PubMed ID: 6189110
[TBL] [Abstract][Full Text] [Related]
19. Biochemical parameters as prognostic factors in prostatic adenocarcinoma.
Vesalainen S; Lipponen P; Talja M; Syrjänen K
Acta Oncol; 1995; 34(1):53-9. PubMed ID: 7865237
[TBL] [Abstract][Full Text] [Related]
20. Circadian and day-to-day variation of prostatic acid phosphatase.
Nissenkorn I; Mickey DD; Miller DB; Soloway MS
J Urol; 1982 Jun; 127(6):1122-4. PubMed ID: 6177878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
